Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-08

FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA issued a supplemental approval for fentanyl transdermal product submitted by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fentanyl transdermal (fentanyl transdermal system)

Snippet

SUPPL AP for FENTANYL TRANSDERMAL (FENTANYL TRANSDERMAL)